Quarterly report pursuant to Section 13 or 15(d)

Schedule of Assets Acquired and Liabilities Assumed (Details)

v3.21.2
Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Oct. 23, 2021
Sep. 30, 2021
Aug. 10, 2021
Dec. 31, 2020
Oct. 23, 2020
Business Acquisition [Line Items]          
Goodwill $ 901 $ 1,385   $ 901  
Nebula Acquisition [Member]          
Business Acquisition [Line Items]          
Short term investments     $ 1,800    
Accounts receivable     222    
Inventory     435    
Prepaid and other current assets     379    
Definite-lived intangible asset     10,990    
Total assets acquired     13,826    
Accounts payable     (372)    
Accrued expenses and other current liabilities     (43)    
Deferred revenue     (1,140)    
Note payable     (81)    
Liabilities assumed     (1,636)    
Net identifiable assets acquired     12,190    
Goodwill     484    
Total consideration [1]     $ 12,674    
C P M Acquisition [Member]          
Business Acquisition [Line Items]          
Clinical lab material         $ 180
Lab equipment         112
Definite-lived intangible asset         1,307
Total assets acquired         1,599
Liabilities assumed        
Net identifiable assets acquired         1,599
Goodwill         901
Total consideration         $ 2,500
[1] Net of $1,639 cash acquired and $257 anticipated amounts due back to the Company from the escrow account.